5-Karboksamidotriptamin

Из Википедије, слободне енциклопедије
Иди на навигацију Иди на претрагу
5-Karboksamidotriptamin
5-Carboxamidotryptamine.png
IUPAC ime
3-(2-aminoethyl)-1H-indole-5-carboxamide
Identifikatori
CAS broj 74885-09-9 ДаY
ATC kod None
PubChem CID 1809
IUPHAR/BPS 4
ChemSpider 1743 ДаY
ChEMBL CHEMBL18840 ДаY
Hemijski podaci
Formula C11H13N3O
Molarna masa 203.240 g/mol

5-Karboksamidotriptamin (5-CT) je triptaminski derivat koji je blisko srodan sa neurotransmiterom serotoninom.

5-CT deluje kao neselektivni pun agonist visokog afiniteta na 5-HT1A, 5-HT1B, 5-HT1D, 5-HT5A, i 5-HT7 receptore, kao i na 5-HT2, 5-HT3, 5-HT6 receptore sa nižim afinitetom.[1][2][3] On ima neznatan afinitet za 5-HT1E i 5-HT1F receptore.[4] 5-CT se najjače vezuje za 5-HT1A receptor i nekad se smatralo da je selektivan za njega.[5][6]

Vidi još[уреди]

Literatura[уреди]

  1. ^ Yamada J, Sugimoto Y, Noma T, Yoshikawa T (1998). „Effects of the non-selective 5-HT receptor agonist, 5-carboxamidotryptamine, on plasma glucose levels in rats.”. Eur J Pharmacol. 359 (1): 81—86. PMID 9831297. doi:10.1016/S0014-2999(98)00617-7. 
  2. ^ Wright, CE; Angus, JA (1989). „5-carboxamidotryptamine elicits 5-HT2 and 5-HT3 receptor-mediated cardiovascular responses in the conscious rabbit: evidence for 5-HT release from platelets.”. Journal of cardiovascular pharmacology. 13 (4): 557—64. PMID 2470992. 
  3. ^ Glennon RA, Dukat M, Westkaemper RB (01. 01. 2000). „Serotonin Receptor Subtypes and Ligands”. American College of Neurophyscopharmacology. Приступљено 11. 04. 2008. 
  4. ^ Stanton JA, Middlemiss DN, Beer MS (1996). „Autoradiographic localization of 5-CT-insensitive 5-HT1-like recognition sites in guinea pig and rat brain.”. Neuropharmacology. 35 (2): 223—229. PMID 8734492. doi:10.1016/0028-3908(95)00178-6. 
  5. ^ Thomas, DR; Middlemiss, DN; Taylor, SG; Nelson, P; Brown, AM (1999). „5-CT stimulation of adenylyl cyclase activity in guinea-pig hippocampus: evidence for involvement of 5-HT7 and 5-HT1A receptors.”. British journal of pharmacology. 128 (1): 158—64. PMC 1571602Слободан приступ. PMID 10498847. doi:10.1038/sj.bjp.0702759. 
  6. ^ Saxena, PR; Lawang, A (1985). „A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors.”. Archives internationales de pharmacodynamie et de therapie. 277 (2): 235—52. PMID 2933009.